Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Diverse groups of experts helped assess the relationships between drivers on an extended time-horizon: assessing either no connection, some connection or a strong connection between two drivers along any of their possible future trajectories.
This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
This report presents surveillance data on Clostridioides (Clostridium) difficile infection (CDI) in acute care hospitals in European Union/European Economic Area (EU/EEA) countries, the UK, and Serbia.
ECDC works together with the institutions and agencies of the EU, in particular the European Commission’s Directorate-General for Health and Food Safety (DG SANTE), the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).